dc.creator | Vallès, Ermengol | es |
dc.creator | Jiménez, Jesús | es |
dc.creator | Martí Almor, Julio | es |
dc.creator | Toquero, Jorge | es |
dc.creator | Ormaetxe, José Miguel | es |
dc.creator | Barrera, Alberto | es |
dc.creator | Cózar León, Rocío | es |
dc.creator | Martínez-Alday, Jesús Daniel | es |
dc.date.accessioned | 2022-10-10T17:48:41Z | |
dc.date.available | 2022-10-10T17:48:41Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Vallès, E., Jiménez, J., Martí Almor, J., Toquero, J., Ormaetxe, J.M., Barrera, A.,...,Martínez-Alday, J.D. (2022). Cryoballoon Ablation for Persistent and Paroxysmal Atrial Fibrillation: Procedural Differences and Results from the Spanish Registry (RECABA). Journal of Clinical Medicine, 11 (5), 1-12. https://doi.org/10.3390/jcm11051166. | |
dc.identifier.issn | 2077-0383 | es |
dc.identifier.uri | https://hdl.handle.net/11441/137785 | |
dc.description.abstract | Introduction: Cryoballoon ablation (CBA) has become a standard treatment for paroxysmal
atrial fibrillation (PaAF) but limited data is available for outcomes in patients with persistent atrial
fibrillation (PeAF). Methods: We analyzed the first 944 patients included in the Spanish Prospective
Multi-center Observation Post-market Registry to compare characteristics and outcomes of patients
undergoing CBA for PeAF versus PaAF. Results: A total of 944 patients (57.8 ± 10.4 years; 70.1%
male) with AF (27.9% persistent) were prospectively included from 25 centers. PeAF patients were
more likely to have structural heart disease (67.7 vs. 11.4%; p < 0.001) and left atrium dilation
(72.6 vs. 43.3%; p < 0.001). CBA of PeAF was less likely to be performed under general anesthesia
(10.7 vs. 22.2%; p < 0.001), with an arterial line (32.2 vs. 44.6%; p < 0.001) and assisted transeptal
puncture (11.9 vs. 17.9%; p = 0.025). During an application, PeAF patients had a longer time to
−30 ◦C (35.91 ± 14.20 vs. 34.93 ± 12.87 s; p = 0.021) and a colder balloon nadir temperature during
vein isolation (−35.04 ± 9.58 vs. −33.61 ± 10.32 ◦C; p = 0.004), but received fewer bonus freeze
applications (30.7 vs. 41.1%; p < 0.001). There were no differences in acute pulmonary vein isolation
and procedure-related complications. Overall, 76.7% of patients were free from AF recurrences
at 15-month follow-up (78.9% in PaAF vs. 70.9% in PeAF; p = 0.09). Conclusions: Patients with
PeAF have a more diseased substrate, and CBA procedures performed in such patients were more
simplified, although longer/colder freeze applications were often applied. The acute efficacy/safety
profile of CBA was similar between PaAF and PeAF patients, but long-term results were better in
PaAF patients. | es |
dc.format | application/pdf | es |
dc.format.extent | 12 p. | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.relation.ispartof | Journal of Clinical Medicine, 11 (5), 1-12. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Persistent atrial fibrillation | es |
dc.subject | Cryoballoon procedure | es |
dc.subject | Registry | es |
dc.title | Cryoballoon Ablation for Persistent and Paroxysmal Atrial Fibrillation: Procedural Differences and Results from the Spanish Registry (RECABA) | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Medicina | es |
dc.relation.publisherversion | https://www.mdpi.com/2077-0383/11/5/1166 | es |
dc.identifier.doi | 10.3390/jcm11051166 | es |
dc.journaltitle | Journal of Clinical Medicine | es |
dc.publication.volumen | 11 | es |
dc.publication.issue | 5 | es |
dc.publication.initialPage | 1 | es |
dc.publication.endPage | 12 | es |